Articles
S.M. Pyvovar, I.S. Rudyk, T.V. Lozyk. Damage of the cardiovascular system in lysosomal storage disease - mucopolysaccharidosis - review. Pol Merkur Lekarski . 2021 Dec 16;49(294):448-452. PMID: 34919092
The analysis of literature data reflecting the issues of the pathology of the cardiovascular system in mucopolysaccharidosis are presented. It was found out that heart and vessels damage is one of the cardinal signs of this pathology, often leading…
Read MoreS. Pyvovar , IS. Rudik , OO. Medentseva. The significance of the level of triiodothyronium in the diagnosis of the syndrome of "low triiodothyronine" in heart failure. ESC Congress 2021 - The Digital Experience. Abstract 81262
Heart failure (HF) is an important issue in cardiology. Some patients with HF have the low T3 syndrome (LT3S). There is no consensus regarding the criteria for determining LT3S. The purpose is to study the features of LT3S determination in HF and…
Read MoreS. Pyvovar, IS. Rudyk. The association of Beta-adrenoreception system genes polymorphisms and interleukins levels in patients with heart failure. Heart Failure 2021 Online Congress. Abstract 60740
The aim: to study the relationship of the β-adrenoreception system (β-ARs) genes polymorphisms withinterleukins (IL) levels in patients with heart failure (HF). Materials and methods. 285 patients with heart failure on the background of post-…
Read MoreS.M. Pyvovar, Yu.S. Rudyk. L.V. Panina. THE POSSIBILITY OF USING THE LEVOTHYROXINE IN PATIENTS WITH HEART FAILURE. Therapeutic Journal. 2021;3
The study included 218 patients with heart failure (HF) on the background of post-infarction cardiosclerosis. 109 (50.0%) patients with AIT received LT due to hypothyreosis in past. These patients intake LT during 2 years before included in the…
Read MoreRudyk Yr.S., Pyvovar S.M. COVID-19 and disease cardiovascular system: in focus - heart failure. Health of Ukraine. 2021: 4 (497) ; 42-44
https://health-ua.com/article/64444-COVID19--zahvoryuvannya--sertcevosudinno-sistemi-ufokus--sertceva-nedostatn 2020 was marked by an unprecedented effort by humanity to combat the coronavirus pandemic (COVID ‑ 19) and was an extremely difficult…
Read MorePyvоvar SM, Rudyk YuS, Krоtоva О. B., Panina LV. Comorbid conditions at chronic obstructive pulmonary disease: the questions under investigation and discussion. Part 2 [in Urkainian]. Ukrainian Therapeutic Journal. 2021;2:74-79. http://doi.org/10.30978/UT
Thyroid hormone therapy in the setting of heart failure is still an "open book" today. There are several unanswered questions: the regimen, doses and schedule of the use of thyroid hormones, the consequences of such therapy. At the same time, the…
Read MorePyvovar S., Rudyk I.S., Medentseva O.O., et al. Influence of low triiodothyronine syndrome on the course of heart failure in patients with a history of myocardial infarction. (HFA Discoveries 2020). European Journal of Heart Failure. 2020;22(Suppl. S1):55
Background: Progression of heart failure (HF) leads to hormonal changes, including low triiodothyronine syndrome (LT3S). The LT3S that accompanies HF can lead to a number of disorders, including the reduction of systolic heart function, the…
Read MorePyvovar S.M., Rudyk I.S., Lozyk T.V., Galchinskaya V.Yu., Chenchik T.O. The effect of beta-blockers on a course of chronic heart failure in patients with a low triiodothyronine syndrome. Wiadomosci Lekarskie. 2020;73(7):1402-1409.
Introduction: Progression of heart failure (HF) leads to hormonal changes, including low triiodothyronine syndrome (LT3S). b-blockers (b-AB) reduce the activity of deiodinases, which leads to a decrease in triiodothyronine (T3) levels. Presumably…
Read MorePyvovar S.M., Rudyk Yu.S., Lozyk T.V., et al. Association of clinical course of heart failure with interleukin levels in patients with non-toxic goiter. Bulletin of problems of biology and medicine. 2020;1(3);(155):187-193.
Abstract. Heart failure (HF), as the final stage of the cardiovascular continuum, is associated with high mortality in most countries of the world. It is known that concomitant diseases and dynamics of a number of hormones, biomarkers, including…
Read MoreS. Pyvovar, I. Rudyk, T. Lozyk, et al. The association of beta-adrenoreception system genes polymorphisms and interleukins levels in patients with heart failure and non-toxic goiter. UKRAINIAN THERAPEUTIC JOURNAL. 2020;1:61-69.
The aim: to study the relationship of the -adrenoreception system (-ARs) genes polymorphisms with interleukins (IL) levels in patients with heart failure (HF) and non-toxic goiter (NG). Materials and methods. 285 patients with heart failure on the…
Read More